Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1015 results for "glaxo"

GlaxoSmithKline PLC (GSK) Showing Bearish Technicals With Supp...

The patented option-trade picking algorithms that power's Artificial Intelligence Center Aare highlighting two trades on GlaxoSmithKline Plc ("GSK) today after it closed ..., 1 hour ago

449 images for glaxo

American Banking News, 14 hours ago
Yahoo! UK and Ireland, 16 hours ago
Reuters, 19 hours ago
Reuters, 1 day ago
New Age Bangladesh, 2 days ago
Wall Street Pit, 6 days ago
Wall Street Pit, 6 days ago
Wall Street Pit, 6 days ago
Wall Street Pit, 6 days ago
Wall Street Pit, 6 days ago

NICE says 'yes' to GSK's melanoma pill, but only with a price cut

Britain's drug price watchdog, the National Institute for Health and Care Excellence (NICE), has given the go-ahead to GlaxoSmithKline's ($GSK) Tafinlar, which is among the new class of melanoma drugs that target tumor mutations. Not surprisingly, ...
 FiercePharma38 minutes ago GSK melanoma drug sees quick NICE nod  Pharmafocus3 hours ago Could GlaxoSmithKline Be A Better Investment Than Gilead?  Seeking Alpha1 day ago NICE backs GlaxoSmithKline's melanoma therapy Tafinlar  FirstWord Pharma8 hours ago

Glaxo Ebola vax shows no adverse effects so far in first human trial

NIAID Director Dr. Anthony Fauci With the Ebola death toll mounting in West Africa, a Phase I trial of GlaxoSmithKline's ( $GSK ) experimental vaccine for the disease is underway at the U.S. National Institutes of Health. And so far, health ...
 FiercePharma38 minutes ago Ebola vaccine trial gets underway in the UK  EuroNews11 hours ago First UK volunteer gets experimental GSK Ebola shot in trial  CHINAdaily10 hours ago First UK volunteer gets trial Ebola shot  Oman Observer1 day ago

GSK seeks commercial licence from Five Prime for muscle disease treatment

GlaxoSmithKline (GSK) has acquired a commercial licence from Five Prime Therapeutics by exercising an option for products to treat undisclosed muscle disease. The option is to secure an exclusive and worldwide license for products, which are ...
 Pharmaceutical Technology22 hours ago Five Prime: Option Exercise By Glaxo For License To Muscle Disease Target  RTTNews.com2 days ago GlaxoSmithKline Exercises Option For Five Prime Therapeutics, Inc.'s Skeletal Muscle Drugs  BioSpace1 day ago Five Prime: Glaxo Exercises Option for Rights to Muscle-Disease Products  Nasdaq2 days ago

3 Stocks To Transform Your Portfolio: HSBC Holdings plc, GlaxoSmithKline plc And Banco Santander SA

Sometimes, it's difficult to find high-quality companies trading at attractive valuations. Indeed, during bull markets it can be especially tough, as valuations become rather excessive. However, with the FTSE 100 still being at roughly the same ...
 Yahoo! UK and Ireland5 hours ago

Five Prime Therapeutics' Novel Target Licensed by Glaxo

Five Prime Therapeutics, Inc. ( FPRX ) announced that GlaxoSmithKline ( GSK ) has decided to exercise its option to gain an exclusive worldwide license to products containing an undisclosed muscle disease target developed by using Five Prime's ...
 Yahoo! Finance20 hours ago GSK and Theravance Announce Initiation of Phase III Programme With Fixed Dose Triple Combination Treatment FF/UMEC/VI in Patients With COPD  Andhra News2 months ago

Dr Reddy's-GSK pact runs into rough weather, review likely

Summary An agreement between GlaxoSmithKline Plc and Dr Reddy's Laboratories... An agreement between GlaxoSmithKline Plc and Dr Reddy's Laboratories (DRL) to develop and market select products across emerging markets outside India ...
 Financial Express22 hours ago

GSK On Track To Develop Safe And Tested Ebola Vaccine

The National Institute of Health (NIH) Director has said in a testimony to a US Senate panel that GlaxoSmithKline's Ebola vaccine has so far been safe in human trials. Meanwhile, Obama has called for greater global action to fight the epidemic ...
 Bidness Etc1 day ago Briton is first to try Ebola vaccine  Big News Network23 hours ago

GSK share price: UK healthcare watchdog backs group's melanoma drug, Thursday, September 18: A skin cancer drug developed by GlaxoSmithKline Plc (LON:GSK) has been recommended by the UK healthcare agency NICE, The Telegraph has reported. The recommendation came after the FTSE 100 drugmaker agreed to ...
 Invezz3 hours ago UK's NICE Wins Drug Price War With GSK  American Journal of Managed Care3 hours ago UK Regulator Recommends GSK's Skin Cancer Drug  Bidness Etc3 hours ago Cut-price GSK skin cancer drug wins Nice approval  Yahoo! UK and Ireland10 hours ago

Mylan initiates Phase III asthma and diabetes trials

Mylan Inc., a generic drug company, has initiated Phase III clinical trials for its generic version of GlaxoSmithKline's Advair Diskus for asthma and its insulin analog to Sanofi's Lantus. In October 2014, Mylan will commence a Phase III clinical ...
 Individual.com1 day ago Mylan Commences Clinical Trials for Generic Versions of Advair Diskus and Insulin Analog to Lantus  Big News Network1 day ago Merck's weekly diabetes drug stacks up to blockbuster Januvia in Phase III  FierceBiotech5 hours ago Mylan to test generic version of Advair Diskus for asthma treatment  Orthopedics Today1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less